FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963238421> ?p ?o ?g. }

• W2963238421 endingPage "e1002848" @default.
• W2963238421 startingPage "e1002848" @default.
• W2963238421 abstract "Background Metformin is increasingly offered as an acceptable and economic alternative to insulin for treatment of gestational diabetes mellitus (GDM) in many countries. However, the impact of maternal metformin treatment on the trajectory of fetal, infant, and childhood growth is unknown. Methods and findings PubMed, Ovid Embase, Medline, Web of Science, ClinicalTrials.gov, and the Cochrane database were systematically searched (from database inception to 26 February 2019). Outcomes of GDM-affected pregnancies randomised to treatment with metformin versus insulin were included (randomised controlled trials and prospective randomised controlled studies) from cohorts including European, American, Asian, Australian, and African women. Studies including pregnant women with pre-existing diabetes or non-diabetic women were excluded, as were trials comparing metformin treatment with oral glucose-lowering agents other than insulin. Two reviewers independently assessed articles for eligibility and risk of bias, and conflicts were resolved by a third reviewer. Outcome measures were parameters of fetal, infant, and childhood growth, including weight, height, BMI, and body composition. In total, 28 studies (n = 3,976 participants) met eligibility criteria and were included in the meta-analysis. No studies reported fetal growth parameters; 19 studies (n = 3,723 neonates) reported measures of neonatal growth. Neonates born to metformin-treated mothers had lower birth weights (mean difference −107.7 g, 95% CI −182.3 to −32.7, I2 = 83%, p = 0.005) and lower ponderal indices (mean difference −0.13 kg/m3, 95% CI −0.26 to 0.00, I2 = 0%, p = 0.04) than neonates of insulin-treated mothers. The odds of macrosomia (odds ratio [OR] 0.59, 95% CI 0.46 to 0.77, p < 0.001) and large for gestational age (OR 0.78, 95% CI 0.62 to 0.99, p = 0.04) were lower following maternal treatment with metformin compared to insulin. There was no difference in neonatal height or incidence of small for gestational age between groups. Two studies (n = 411 infants) reported measures of infant growth (18–24 months of age). In contrast to the neonatal phase, metformin-exposed infants were significantly heavier than those in the insulin-exposed group (mean difference 440 g, 95% CI 50 to 830, I2 = 4%, p = 0.03). Three studies (n = 520 children) reported mid-childhood growth parameters (5–9 years). In mid-childhood, BMI was significantly higher (mean difference 0.78 kg/m2, 95% CI 0.23 to 1.33, I2 = 7%, p = 0.005) following metformin exposure than following insulin exposure, although the difference in absolute weights between the groups was not significantly different (p = 0.09). Limited evidence (1 study with data treated as 2 cohorts) suggested that adiposity indices (abdominal [p = 0.02] and visceral [p = 0.03] fat volumes) may be higher in children born to metformin-treated compared to insulin-treated mothers. Study limitations include heterogeneity in metformin dosing, heterogeneity in diagnostic criteria for GDM, and the scarcity of reporting of childhood outcomes. Conclusions Following intrauterine exposure to metformin for treatment of maternal GDM, neonates are significantly smaller than neonates whose mothers were treated with insulin during pregnancy. Despite lower average birth weight, metformin-exposed children appear to experience accelerated postnatal growth, resulting in heavier infants and higher BMI by mid-childhood compared to children whose mothers were treated with insulin. Such patterns of low birth weight and postnatal catch-up growth have been reported to be associated with adverse long-term cardio-metabolic outcomes. This suggests a need for further studies examining longitudinal perinatal and childhood outcomes following intrauterine metformin exposure. This review protocol was registered with PROSPERO under registration number CRD42018117503." @default.
• W2963238421 created "2019-07-30" @default.
• W2963238421 creator A5053840716 @default.
• W2963238421 creator A5054905393 @default.
• W2963238421 creator A5086595936 @default.
• W2963238421 date "2019-08-06" @default.
• W2963238421 modified "2023-10-15" @default.
• W2963238421 title "Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis" @default.
• W2963238421 cites W1001416930 @default.
• W2963238421 cites W1073087283 @default.
• W2963238421 cites W1518577797 @default.
• W2963238421 cites W1561278284 @default.
• W2963238421 cites W1592674309 @default.
• W2963238421 cites W1967855721 @default.
• W2963238421 cites W1971440866 @default.
• W2963238421 cites W1973061822 @default.
• W2963238421 cites W1979915761 @default.
• W2963238421 cites W1990414793 @default.
• W2963238421 cites W1992355896 @default.
• W2963238421 cites W1995069275 @default.
• W2963238421 cites W1998227809 @default.
• W2963238421 cites W2001340600 @default.
• W2963238421 cites W2003621575 @default.
• W2963238421 cites W2005501262 @default.
• W2963238421 cites W2011576149 @default.
• W2963238421 cites W2035616843 @default.
• W2963238421 cites W2052130063 @default.
• W2963238421 cites W2061072286 @default.
• W2963238421 cites W2080231032 @default.
• W2963238421 cites W2080904226 @default.
• W2963238421 cites W2086685908 @default.
• W2963238421 cites W2095656478 @default.
• W2963238421 cites W2102307174 @default.
• W2963238421 cites W2113909175 @default.
• W2963238421 cites W2123528920 @default.
• W2963238421 cites W2130583716 @default.
• W2963238421 cites W2144199745 @default.
• W2963238421 cites W2148992039 @default.
• W2963238421 cites W2152958267 @default.
• W2963238421 cites W2154737841 @default.
• W2963238421 cites W2164882663 @default.
• W2963238421 cites W2167864556 @default.
• W2963238421 cites W2168050440 @default.
• W2963238421 cites W2169476389 @default.
• W2963238421 cites W2171865413 @default.
• W2963238421 cites W2255104527 @default.
• W2963238421 cites W2297880637 @default.
• W2963238421 cites W2321354657 @default.
• W2963238421 cites W2339824791 @default.
• W2963238421 cites W2399130742 @default.
• W2963238421 cites W2415363579 @default.
• W2963238421 cites W2423792150 @default.
• W2963238421 cites W2511029118 @default.
• W2963238421 cites W2572741715 @default.
• W2963238421 cites W2595836458 @default.
• W2963238421 cites W2621654760 @default.
• W2963238421 cites W2739928654 @default.
• W2963238421 cites W2766087058 @default.
• W2963238421 cites W2790276328 @default.
• W2963238421 cites W2790452671 @default.
• W2963238421 cites W2808052171 @default.
• W2963238421 cites W2811008851 @default.
• W2963238421 cites W2889009120 @default.
• W2963238421 cites W2890203399 @default.
• W2963238421 cites W2894158724 @default.
• W2963238421 cites W2912929349 @default.
• W2963238421 cites W2919748437 @default.
• W2963238421 cites W4248871223 @default.
• W2963238421 cites W4292337504 @default.
• W2963238421 doi "https://doi.org/10.1371/journal.pmed.1002848" @default.
• W2963238421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6684046" @default.
• W2963238421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31386659" @default.
• W2963238421 hasPublicationYear "2019" @default.
• W2963238421 type Work @default.
• W2963238421 sameAs 2963238421 @default.
• W2963238421 citedByCount "117" @default.
• W2963238421 countsByYear W29632384212019 @default.
• W2963238421 countsByYear W29632384212020 @default.
• W2963238421 countsByYear W29632384212021 @default.
• W2963238421 countsByYear W29632384212022 @default.
• W2963238421 countsByYear W29632384212023 @default.
• W2963238421 crossrefType "journal-article" @default.
• W2963238421 hasAuthorship W2963238421A5053840716 @default.
• W2963238421 hasAuthorship W2963238421A5054905393 @default.
• W2963238421 hasAuthorship W2963238421A5086595936 @default.
• W2963238421 hasBestOaLocation W29632384211 @default.
• W2963238421 hasConcept C126322002 @default.
• W2963238421 hasConcept C131872663 @default.
• W2963238421 hasConcept C134018914 @default.
• W2963238421 hasConcept C156957248 @default.
• W2963238421 hasConcept C187212893 @default.
• W2963238421 hasConcept C188816634 @default.
• W2963238421 hasConcept C2779234561 @default.
• W2963238421 hasConcept C2779306644 @default.
• W2963238421 hasConcept C2779434492 @default.
• W2963238421 hasConcept C2780323712 @default.
• W2963238421 hasConcept C2780938740 @default.
• W2963238421 hasConcept C46973012 @default.

• next